Llwytho...
From On-Target to Off-Target Activity: Identification and Optimisation of Trypanosoma brucei GSK3 Inhibitors and Their Characterisation as Anti-Trypanosoma brucei Drug Discovery Lead Molecules
Human African trypanosomiasis (HAT) is a life-threatening disease with approximately 30 000–40 000 new cases each year. Trypanosoma brucei protein kinase GSK3 short (TbGSK3) is required for parasite growth and survival. Herein we report a screen of a focused kinase library against T. brucei GSK3. Fr...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , , , , , , |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
WILEY-VCH Verlag
2013
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3728731/ https://ncbi.nlm.nih.gov/pubmed/23776181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.201300072 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|